May 02, 2022
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of the type of biopharmaceutical products innovated and launched, evolving from management of chronic diseases in the 1990s to the expansive marketing of generic drugs, to now moving onto personalized therapies. To increase the suc...
Read More...
Feb 11, 2022
Today, the most important factor affecting the world’s economy is the Global Pharmaceutical Industry. This industry is at the forefront driving about one trillion dollars annually. Pharmaceutical companies are driving a major share of the global economy with the rapidly advancing technological and scientific base, ...
Read More...
Oct 27, 2021
The Pharmaceuticals segment of the Healthcare Industry has a significant market across the globe, which has grown quite extensively in the past few decades. The pharmaceutical sector has always been at the forefront of drug discovery, development, production, and marketing. The pharmaceutical industry in the twenty...
Read More...
Aug 25, 2021
Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, ...
Read More...
Jan 16, 2019
A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...
Read More...
Aug 27, 2018
As part of its “Made in China 2025” industrial plan, China hopes to reinvent its pharmaceutical industry. President Xi Jinping has identified his country’s reliance on foreign drug imports as a critical concern. China’s enormous population, coupled with the rise of disease and illness, make the country a prime marke...
Read More...
Dec 08, 2016
With $496M CNS sale, Novartis joins other Pharma companies casting off tired meds The latest Big Pharma to join the asset-sale party is Novartis, which is in talks to offload some of its older central nervous system (CNS) drugs, including Ritalin for attention deficit disorder and Exelon patch for Alzheimer’s. The p...
Read More...
Oct 25, 2016
Boston Biomedical starts phase III study of Napabucasin Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathways, announced dosing of the first patient in CanStem303C, a new global phase III study investigating napabucasin in combination with standard of...
Read More...
Oct 18, 2016
Merck launches Biosimilars Clarified, a new online educational resource about biosimilar medicines for patients and the healthcare community Merck has announced the launch of Biosimilars Clarified, a new educational website for patients, caregivers and the healthcare community that is designed to provide clear, conc...
Read More...
Aug 27, 2014
DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports. VISIT OUR WEBSITE Infectious Diseases and Vaccines The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a fi...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper